FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On September 5, 2006
Table of Contents
Docket # Title
1978N-0065 Skin Bleaching Drug Products
1992N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992
1999P-1340 Declared Eternity eau de Parfum Misbranded
2001D-0489 Establishment & Operation of Clinical Trial Monitoring Comm
2005D-0169 Guidance on Useful Written Consumer Medication Information (CMI)
2005D-0202 Guidance for Industry on Bar Code Label Requirements; Questions and Answers
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
2006P-0114 Refrain from taking administrative action regarding approval and/or effective date of final approval of any and all ANDAs for a generic version of Metrogel-Vaginal 0.75%
2006P-0151 Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
2006P-0158 Revoke regulations that provided for the inclusion and addition of sucralose as a non-nutritive sweetener in food
2006P-0186 Withdraw new drug application (NDA 21-179) for Renagel Tablets (sevelamer hydrochloride) 400 and 800 mg
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
2006P-0310 Compel the Agency to follow requirements of the Drug Listing Act of 1972
2006P-0346 Ban Marketing of Estratest, Estratest H.S. and Syntest D.S. and Syntest H.S. associated with Menopause
2006P-0360 Determine that the discontinued formulation of Carbocaine Injection, 3% supplied in 1.8 mL cartridge was not discontinued for safety and efficacy reasons
2006P-0364 Reformulation of central nervous system (CNS) stimulant drugs
2006P-0365 Citizen Petition Urging FDA to Take Regulatory Action to Safeguard the Public from Violative Dental Devices Distributed by Five Companies, Including Devices Manufactured in Unregistered Facilities and
1978N-0065 Skin Bleaching Drug Products
EC 3 Mrs. Peggy Brown Vol #: 4
EC 4 Ms. Parisa Fitz-Henley Vol #: 4
EC 5 Miss. Laura Laine-McInnis Vol #: 4
1992N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992
EMC 5 D. McNabb Vol #: 10
1999P-1340 Declared Eternity eau de Parfum Misbranded
EMC 649 M. Ruhl Vol #: 24
2001D-0489 Establishment & Operation of Clinical Trial Monitoring Comm
EC 18 Mr. Dave Lowe Vol #: 2
2005D-0169 Guidance on Useful Written Consumer Medication Information (CMI)
EC 19 Mr. Dave Lowe Vol #: 2
2005D-0202 Guidance for Industry on Bar Code Label Requirements; Questions and Answers
EC 5 Mr. Dave Lowe Vol #: 1
2005H-0271 Civil Money Penalty: TMJ Implants, Inc.
MO 17 TMJ Implants, Inc., and Robert W. Christensen and Maureen K. Mooney Vol #: 6
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
EC 33269 Florida Pharmacy Association Vol #: 197
EC 33270 Ms. Kerry Finn Vol #: 197
EC 33271 Ms. Delma J. Soriano Vol #: 197
EMC 3850 L. Mercury Vol #: 195
EMC 3851 P. Fyne Vol #: 195
EMC 3852 T. Frank Vol #: 195
EMC 3853 C. Benoit Vol #: 195
EMC 3854 K. Dydo Vol #: 195
EMC 3855 N. Joyner Vol #: 195
EMC 3856 J. Jenschke Vol #: 195
EMC 3857 K. Reichert Vol #: 195
EMC 3858 V. Dorris Vol #: 195
EMC 3859 R. Myers Vol #: 195
EMC 3860 C. St. John-Harden Vol #: 195
EMC 3861 E. Barkley Vol #: 195
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
EC 1 Mr. Darryl Wellinghoff Vol #: 1
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
EC 1 Ms. Shonagh Home Vol #: 3
EC 2 Ms. Kimela Lanford Vol #: 3
EC 3 Mr. Gary Herring Vol #: 3
EC 4 Mrs. Karen Newman Vol #: 3
EC 5 Mr. Venkat Rangamani Vol #: 3
EC 6 Concerned Citizen : ending mercury in dental work Vol #: 3
EC 7 Ms. Lauri Pruett Vol #: 3
EC 8 Ms. Judy Klien Vol #: 3
EC 9 Mr. Roger Nelson Vol #: 3
EC 10 American Dental Association Vol #: 3
EC 11 American Dental Association Vol #: 3
EC 12 American Dental Association Vol #: 3
EC 13 Mrs. Sandra osborne Vol #: 3
EC 14 Dr. B Lafferty Vol #: 3
EC 15 Mr. Steven White DTR Vol #: 3
EC 16 Mrs. Lisa Porter Vol #: 3
EC 17 Mr. Lane Weaver Vol #: 3
EC 18 Ms. RoseMary Volpe Vol #: 3
EC 19 Dr. Pauline Hattemer Vol #: 3
EC 20 Mrs. Diane Harrell Vol #: 3
EC 21 Mr. Max Kane Vol #: 3
EC 22 IAOMT Vol #: 4
EC 23 Mr. Charles Spencer Vol #: 3
EC 24 Univ. of Georgia Vol #: 3
EC 25 Mrs. Teresa Irvin Vol #: 3
EC 26 Mrs. Christine Cave Vol #: 3
EC 27 Ms. Judith Ross Vol #: 3
EC 28 Mrs. Monica Thomas Vol #: 3
EC 29 Ms. Bobby McClintock Vol #: 3
EC 30 Mrs. Diana Green Vol #: 3
EC 31 Mountain View Citizens for Safe Drinking Water Vol #: 3
EC 32 Dr. William Harris Vol #: 3
EC 33 Fluoride Action Network Vol #: 3
EC 34 Mrs. VERNA DISTAD Vol #: 3
EC 35 Mrs. Maggie Overdahl Vol #: 3
EC 36 Citizen Political Activist Vol #: 3
EC 37 Mr. J. Michael Bryan Vol #: 3
EC 38 Ms. Arran Thomson Vol #: 3
EC 39 Mr. Pondurenga Das Vol #: 3
EC 40 Mrs. Michele Badanek Vol #: 3
EC 41 None Vol #: 3
EC 42 Dr. Steve Markus Vol #: 3
EC 43 Mr. Daniel McCamman Vol #: 3
EC 44 Mrs. Diane Sperber Vol #: 3
EC 45 The Photo Shoppe Vol #: 3
EC 46 Mr. Ulf Bengtsson Vol #: 3
EC 47 Dr. Rosemary Fecteau Vol #: 3
EC 48 Wellness Rx, Inc. Vol #: 3
EC 49 Dr. Andrew Zakarian Vol #: 3
EC 50 Mrs. Marilyn Hageman Vol #: 3
EC 51 Mothers Against Mercury Amalgam / MAMA Vol #: 3
EC 52 Ms. Carolyn Dohrenwend Vol #: 3
EMC 38 Italian Association for Metals and Biocompatibility Research (A.I.R.M.E.B.) Vol #: 2
EMC 39 H. Downing Vol #: 2
EMC 40 O. Woodward Vol #: 2
EMC 41 T. Danysh Vol #: 2
EMC 42 J. Grossman Vol #: 2
EMC 43 R. Kerger Vol #: 2
EMC 44 V. WIlliams Vol #: 2
EMC 45 B. Levy, DDS Vol #: 2
EMC 46 J. Fritzler Vol #: 2
EMC 47 J. Plumb Vol #: 2
EMC 48 S. Pearce Vol #: 2
EMC 49 D. Joelkers Vol #: 2
EMC 50 S. Holmstrom Vol #: 2
EMC 51 C. Griggs Vol #: 2
EMC 52 T. Nocera, B.S., M.A. Vol #: 2
EMC 53 K. Morris Vol #: 2
EMC 54 L. Pellegrini Vol #: 2
EMC 55 D. Mariano Vol #: 2
EMC 56 L. Piatt, MSN, RN Vol #: 2
EMC 57 Dr. K. Chai Vol #: 2
EMC 58 J. Delgado Vol #: 2
EMC 59 D. Coomer Vol #: 2
EMC 60 Dr. R. McGinn Vol #: 2
EMC 61 No signature Vol #: 2
EMC 62 C. Skipper Vol #: 2
EMC 63 Dr. B. Dawson, DC Vol #: 2
EMC 64 B. Huffman Vol #: 2
EMC 65 J. Delgado Vol #: 2
EMC 66 D. Boone Vol #: 2
EMC 67 B. Shelton, MD Vol #: 2
EMC 68 M. Bernstein, M.D., M.S., J.D. Vol #: 2
EMC 69 W. Glaros, DDS Vol #: 2
EMC 70 J. Marcus Vol #: 2
EMC 71 D. MArtin Vol #: 2
EMC 72 O. Duke Vol #: 2
EMC 73 S. Dilks Vol #: 2
EMC 74 L. Crosby Vol #: 2
EMC 75 Susan Vol #: 2
EMC 76 Dr. M. Thoennes Vol #: 2
EMC 77 M. Ortega Vol #: 2
EMC 78 J. Stuart Vol #: 2
EMC 79 V. Walton Vol #: 2
EMC 80 S. Scheckner, DMD Vol #: 2
EMC 81 Y. Tal Vol #: 2
EMC 82 K. Peterson Vol #: 2
EMC 83 J. Marich Vol #: 2
EMC 84 E. BRandt Vol #: 2
EMC 85 J. Marich Vol #: 2
EMC 86 D. MArtin Vol #: 2
EMC 87 C. Spencer Vol #: 2
EMC 88 T. White Vol #: 2
EMC 89 B. Shands Vol #: 2
EMC 90 C. Geyer, RDH Vol #: 2
EMC 91 J. Schaefer Vol #: 2
EMC 92 L. George Vol #: 2
EMC 93 B. Scott, RDH Vol #: 2
EMC 94 S. Kreider, MSIT, RN, CPC Vol #: 2
EMC 95 J. Parfitt Vol #: 2
2006P-0114 Refrain from taking administrative action regarding approval and/or effective date of final approval of any and all ANDAs for a generic version of Metrogel-Vaginal 0.75%
EC 1 Mr. Dave Lowe Vol #: 2
2006P-0151 Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
EC 720 Mrs. tracy sutton Vol #: 3
2006P-0158 Revoke regulations that provided for the inclusion and addition of sucralose as a non-nutritive sweetener in food
EC 1 McNeil Nutritionals, LLC Vol #: 1
2006P-0186 Withdraw new drug application (NDA 21-179) for Renagel Tablets (sevelamer hydrochloride) 400 and 800 mg
EC 2 Mr. Dave Lowe Vol #: 1
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for
filing an ANDA
EC 580 Mr. Glen Stremel Vol #: 5
EC 581 Mr. David Knebelsberger Vol #: 5
EC 582 Dr. theresa mccall Vol #: 5
EC 583 Dr. Larissa Meyer Vol #: 5
EC 584 Mr. Michael Falcone Vol #: 5
EC 585 Mrs. Susan Calhoun Vol #: 5
EC 586 Mr. Steve Bowman Vol #: 5
2006P-0310 Compel the Agency to follow requirements of the Drug Listing Act of 1972
EC 1 Mr. Dave Lowe Vol #: 1
2006P-0346 Ban Marketing of Estratest, Estratest H.S. and Syntest D.S. and Syntest H.S. associated with Menopause
EC 1 Mr. Dave Lowe Vol #: 1
2006P-0360 Determine that the discontinued formulation of Carbocaine Injection, 3% supplied in 1.8 mL cartridge was not discontinued for safety and efficacy reasons
EC 2 Mr. Dave Lowe Vol #: 1
2006P-0364 Reformulation of central nervous system (CNS) stimulant drugs
EC 1 Mr. Dave Lowe Vol #: 1
2006P-0365 Citizen Petition Urging FDA to Take Regulatory Action to Safeguard the Public from Violative Dental Devices Distributed by Five Companies, Including Devices Manufactured in Unregistered Facilities and
ACK 1 FDA/DDM to Kerr Corporation Vol #: 1
CP 1 Kerr Corporation Vol #: 1

Page created on October 6, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management